- Valbenazine Met the Primary Endpoint of Significant (p<0.0001) Improvement in Chorea Severity versus Placebo as Measured by the Unified Huntington s Disease.
Neurocrine Reports Phase 3 Data Evaluating Valbenazine for Huntington s Chorea globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody.
Share this article
Share this article
PALM BEACH, Fla., May 4, 2021 /PRNewswire/ Cognitive assessment and training solutions and programs have been witnessing increasing demand due to rise in literacy rates and improved economic conditions among a growing population, especially in developing economies. These programs and tests help students and other users to determine their psychological functions and pace at which information can be processed by the brain. Tests are carried out to determine a person s ability to learn by identifying their strengths and weaknesses, and then, appropriate assessment and training helps them to overcome their weaknesses. COVID-19 has increased the need for social distancing, which has spurred adoption of online cognitive tests. The pandemic resulted in various organizations shifting towards adoption of digital technologies as well as online operations. Rapid adoption of smartphones in cognitive assessment and clinical research for data collection,
Cognitive Assessment And Training Market Size Expected To Reach $15 65 Billion In 2028 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.